Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> MutationRichard M. Stone, Hartmut Döhner, Sumithra J. Mandrekar et al.|New England Journal of Medicine|2017Cited by 2.2k
Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling OutcomesChunaram Choudhary, Hubert Serve, Jesper V. Olsen et al.|Molecular Cell|2009Cited by 315
Flt3-dependent transformation by inactivating c-Cbl mutations in AMLBülent Sargin, Hubert Serve|Blood|2007Cited by 209
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Jindřich Činátl, Julian J.K. Lohmeyer et al.|Nature Medicine|2016Cited by 185
Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transductionLara Tickenbrock, Hubert Serve|Blood|2005Cited by 109